Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach

Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach

Cases that experienced COVID-19 postvaccination-related thrombosis have been reported after the first dose of ChAdOx1 nCov-19 (Vaxzevria, AstraZeneca) or Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine. These rare thrombotic events were observed within the expected vaccine-induced seroconversion...

Full description

Bibliographic Details
Main Author: George N. Konstantinou
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
spike protein
cross reactivity
signaling peptide
vaccine-induced immune thrombotic thrombocytopenia
blast
chimpanzee adenovirus
vaxzevria
Online Access:http://dx.doi.org/10.1080/21645515.2022.2050654

Internet

http://dx.doi.org/10.1080/21645515.2022.2050654

Similar Items